Brief: Bionano Genomics Q3 Revenue USD 9.3 Million Vs. IBES Estimate USD 9.08 Million
08/11/2023 21:01
Nov 08 (Reuters) - Bionano Genomics Q3 operating expenses USD 116 million. * Q3 adjusted operating expenses USD 31.8 million * Q3 gross margin 30% * Q3 adjusted gross margin 32% * outlook FY revenue USD 35-38 million
Recent news on Bionano Genomics
See all newsBionano Genomics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Bionano Genomics Q2 revenue rises on increased clinical adoption
Brief: Bionano Genomics Q2 Revenue USD 8.2 Million
Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview
Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt